Sarepta Therapeutics, Inc.
SRPT· Nasdaq
SRPTSarepta Therapeutics, Inc.
Filed Mar 13, 2012 · 10-K · 73 days after period end · 0001193125-12-112142
| Metric | Q4 2011 | Q4 2010dderived from reported figures |
|---|---|---|
| Net Income | -$1.41M | — |
| EPS Diluted | -$0.06 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sarepta Therapeutics, Inc. · CIK 873303 · Engraved from SEC EDGAR
ended Dec 31, 2011 · filed Mar 13, 2012 · 73 d after period end
